Нажмите на эту строку чтобы перейти к Новостям сайта "Русский врач"

Перейти
на сайт
журнала
"Врач"
Перейти на сайт журнала "Медицинская сестра"
Перейти на сайт журнала "Фармация"
Перейти на сайт журнала "Молекулярная медицина"
Перейти на сайт журнала "Вопросы биологической, медицинской и фармацевтической химии"
Журнал включен в российские и международные библиотечные и реферативные базы данных

ВАК (Россия)
РИНЦ (Россия)
Эко-Вектор (Россия)

VALIDATION EVALUATION OF THE METHOD OF QUANTITATIVE DETERMINATION OF α(1,2)-L-RHAMNO-α(1,4)-D-GALACTOPYRANOSYLURONANE ACORUS CALAMUS L. IN DOSAGE FORM

DOI: https://doi.org/10.29296/25877313-2024-02-07
Issue: 
2
Year: 
2024

A.V. Zykova
Post-graduate Student, Department of Pharmaceutical Analysis, Siberian State Medical University (Tomsk, Russia)
E-mail: anastasya.zykova@mail.ru
D.A. Isakov
Post-graduate Student, Department of Pharmaceutical Analysis, Siberian State Medical University (Tomsk, Russia)
S.V. Krivoshchekov
Ph.D. (Chem.), Associate Professor, Department of Pharmaceutical Analysis, Siberian State Medical University (Tomsk, Russia)

Introduction. The object of increased attention of researchers is calamus (Acorus calamus L.), for the components of which a wide range of pharma-cological activities have been identified – immunomodulatory, anti-inflammatory, analgesic, antioxidant, neuroprotective, hypolipidemic, antitumor. Ac-cording to previous studies, it was found that α(1,2)-L-rhamno-α(1,4)-D-galactopyranosyluronan, isolated from the rhizomes of Acorus calamus L., has antimetastatic, antiblastoma, and immunomodulatory properties. The substance can also reduce the toxic effect on the hematopoietic system and in-crease the effectiveness of chemotherapy. Based on it, a finished dosage form was obtained - a solution for intravenous administration of 10 mg/ml, which requires the development of valid quality control methods for inclusion in the draft regulatory document on the quality and registration of a new drug. The aim of the study was to determine the metrological characteristics of the chromatographic technique for the quantitative determination of α(1,2)-L-rhamno-α(1,4)-D-galactopyranosyluronan in the finished dosage form. Material and methods. The object of the study was the finished dosage form - a solution for intravenous administration of α(1,2)-L-rhamno-α(1,4)-D-galactopyranosyluronan Acorus calamus L. 10 mg/ml, produced on the basis of the educational establishment of the Technology Implementation Cen-ter of the Federal State Budgetary Educational Institution of Higher Education of the Siberian State Medical University of the Ministry of Health Russia. Quantitative determination was carried out using a Dionex Ultimate 3000 liquid chromatograph (Thermo, Germany) with a refractometric detector RI-101. Validation assessment was carried out according to the following indicators: linearity, accuracy, precision under repeatability conditions. Results. Linear regression analysis of the obtained results using the least squares method showed that the technique is linear in the concentration range of 80–120%. When determining the accuracy, the openability for concentrations of 80, 100 and 120% varied in the range of 99.68–101.96%. The values of the relative standard deviation did not exceed the permissible values when assessing precision 0.82–4.51%. Conclusions. The methodology is valid for the studied indicators and can be recommended for inclusion in the draft regulatory document on quality. The work was carried out within the framework of applied scientific research 720000F.99.1.BN62AB30000 within the framework of state assignment No. 056-00116-23-01.

Keywords: 
chromatography
polysaccharides
α(1
2)-L-rhamno-α(1
4)-D-galactopyranosyluronan.

References: 
  1. Khan M.A., Islam M.T. Analgesic and cytotoxic activity of Acorus calamus L., Kigelia pinnata L., Mangifera indica L. and Tabernaemontana divaricata L. J Pharm Bioallied Sci. 2012; 4(2): 149–154.
  2. Muthuraman A., Singh N. Attenuating effect of Acorus calamus extract in chronic constriction injury induced neuropathic pain in rats: an evidence of anti-oxidative, anti-inflammatory, neuroprotective and calcium inhibitory effects. BMC Complement Altern Med. 2011; 11: 24.
  3. Parab R.S., Mengi S.A. Hypolipidemic activity of Acorus calamus L. in rats. Fitoterapia. 2002; 73(6): 451–455.
  4. Rahamooz Haghighi S., Asadi M.H., Akrami H., Baghizadeh A. Anti-carcinogenic and anti-angiogenic properties of the extracts of Acorus calamus on gastric cancer cells. Avicenna J Phytomed. 2017; 7(2): 145–156.
  5. Lopatina K.A., Safonova E.A., Nevskaya K.V., et al. Effect of Acorus calamus L. Polysaccharide on CD274 and CD326 Expression by Lewis Lung Carcinoma Cells in Mice. Bull Exp Biol Med. 2017; 164(1): 102–105.
  6. Lopatina K. A., Gur'ev A. M., Razina T. G., Amosova i dr. Dejstvie vodorastvorimyh polisaharidov kornevishh aira bolotnogo na funkcional'nuju aktivnost' kletok limfouzlov v uslovijah citostaticheskoj terapii perevivaemoj opuholi. Sibirskij onkologicheskij zhurnal. 2006; 3: 59–63.
  7. Safonova E.A., Razina T.G., Lopatina K.A., i dr. Snizhenie toksicheskogo jeffekta paklitaksela na sistemu krovi vodorastvorimymi polisaharidami mat'-i-machehi obyknovennoj i aira bolotnogo. Sibirskij onkologicheskij zhurnal. 2010; 2: 42–46.
  8. Safonova E.A., Gur'ev A.M., Razina T.G. i dr. Povyshenie jeffektivnosti himioterapii s pomoshh'ju farmakologicheski aktivnyh frakcij, vydelennyh iz polisaharidnogo kompleksa aira bolotnogo (Acorus calamus L.). Rossijskij bioterapevticheskij zhurnal. 2012; 11(4): 55–58.
  9. Neupokoeva O.V., Lopatina K.A., Voronova O.L. i dr. Izuchenie mutagennyh svojstv a(1,2)-1-ramno-a(1,4)-D-galaktopiranoziluronana Acorus calamus L. TMZh. 2015; 2(60): 22–23.
  10. Nasir O. Protective effect of Acorus calamus on kidney and liver functions in healthy mice. Saudi J Biol Sci. 2021; 28(5): 2701–2708.
  11. Gosudarstvennaja farmakopeja Rossijskoj Federacii XV izd. OFS.1.1.0012 Validacija analiticheskih metodik. [Jelektronnoe izdanie]. Rezhim dostupa: https://pharmaco-poeia.regmed.ru/pharmacopoeia/izdanie-15/?PAGEN_1=5
  12. Ershik V.M., Zhebentjaev A.I., Fadeev V.I., Ershik O.A. Validacija metodiki kolichestvennogo opredelenija metoprolola v plazme krovi. Vestnik farmacii. 2011; 3 (53): 51–56.